Cargando…

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer

OBJECTIVE: Post I-131 ablation single-photon emission computed tomography (SPECT)/CT can show radioactive iodine (RAI)-avid cervical metastatic lymph nodes (mLN) in differentiated thyroid cancer. This study aimed to evaluate the incidence of RAI-avid mLN on post I-131 ablation SPECT/CT and the risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chang-Hee, Jung, Ji-hoon, Son, Seung Hyun, Hong, Chae Moon, Jeong, Ju Hye, Jeong, Shin Young, Lee, Sang-Woo, Lee, Jaetae, Ahn, Byeong-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097663/ https://www.ncbi.nlm.nih.gov/pubmed/30118516 http://dx.doi.org/10.1371/journal.pone.0202644

Ejemplares similares

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
por: Oh, Ji Min, et al.
Publicado: (2022)

Radioactive iodine in low- to intermediate-risk papillary thyroid cancer
por: Zhao, Hengqiang, et al.
Publicado: (2022)

The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer
por: Wang, Xiaofei, et al.
Publicado: (2020)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND
por: Blažeković, Ivan, et al.
Publicado: (2018)

Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system
por: Oh, Ji Min, et al.
Publicado: (2018)

Development of an athyroid mouse model using (131)I ablation after preparation with a low-iodine diet
por: Oh, Ji Min, et al.
Publicado: (2017)

SPECT/CT-based dosimetry of salivary glands and iodine-avid lesions following (131)I therapy
por: Abuqbeitah, Mohammad, et al.
Publicado: (2023)

Retraction Note: Radiation Sialadenitis Induced by High-dose Radioactive Iodine Therapy
por: Jeong, Shin Young, et al.
Publicado: (2014)

Lymph Node Metastases Identified at the Post-Ablation 131I SPECT/CT Scan Is a Prognostic Factor of Intermediate-Risk Papillary Thyroid Cancer
por: Jia, Xi, et al.
Publicado: (2022)

Erratum to: Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2016)

Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer
por: Rajendran, Ramya Lakshmi, et al.
Publicado: (2021)

Serum thyroglobulin elevation after needle aspiration of the lymph nodes: the predictive value for detecting metastasis in papillary thyroid cancer patients – a pilot study
por: Hong, Chae Moon, et al.
Publicado: (2019)

Radioactive Iodine Ablation Can Reduce the Structural Recurrence Rate of Intermediate-Risk Papillary Thyroid Microcarcinoma: A Meta-Analysis
por: Zhao, Min, et al.
Publicado: (2022)

Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
por: Al Aamri, Marwa, et al.
Publicado: (2016)

Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience
por: Verma, Priyanka, et al.
Publicado: (2012)

Evaluation of Iodine-123 and Iodine-131 SPECT activity quantification: a Monte Carlo study
por: Morphis, Michaella, et al.
Publicado: (2021)

Outcomes of Radioactive Iodine ((131)I) Therapy among Hyperthyroid patients
por: Khan, Muhammad Sajjad Ali, et al.
Publicado: (2023)

Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2017)

Iodine Uptake in Retroperitoneal Cysts after Radioactive Iodine Treatment
por: Lee, Ji Young, et al.
Publicado: (2020)

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010)

Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment
por: Mortazavi, Seyed Mohammad Javad, et al.
Publicado: (2023)

Dependence of radioactive iodine-131 capture by the lacrimal ducts on the tear production level
por: Yartsev, Vasily D, et al.
Publicado: (2023)

BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer
por: Han, Sang-Ah, et al.
Publicado: (2014)

Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on (18)F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma
por: Jung, Ji-hoon, et al.
Publicado: (2015)

Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer
por: Mohapatra, Tushar, et al.
Publicado: (2012)

Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
por: Sundaram, P. Shanmuga, et al.
Publicado: (2011)

Predictive factors for the outcomes of Graves’ disease patients with radioactive iodine ((131)I) treatment
por: Xing, Yu-Zhuo, et al.
Publicado: (2020)

Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2014)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy
por: Kim, Kyung-Hee, et al.
Publicado: (2015)

“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015)

Iodine-131 avid distant metastasis in differentiated thyroid cancer: An initial institutional experience from the northern part of India
por: Khan, Shoukat Hussain, et al.
Publicado: (2015)

A Phase II Multi-Center, Non-Randomized, Parallel Group, Non-Inferiority Study to Compare the Efficacy of No Radioactive Iodine Remnant Ablation to Remnant Ablation Treatment in Low- to Intermediate-Risk of Papillary Thyroid Cancer: The MOREthyroid Trial Protocol
por: Lee, Eun Kyung, et al.
Publicado: (2020)

Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
por: Nilsson, Joachim N, et al.
Publicado: (2023)

Unexpected radioactive iodine accumulation on whole-body scan after I-131 ablation therapy for differentiated thyroid cancer
por: Iwano, Shingo, et al.
Publicado: (2020)

Crushed Gold Shell Nanoparticles Labeled with Radioactive Iodine as a Theranostic Nanoplatform for Macrophage-Mediated Photothermal Therapy
por: Lee, Sang Bong, et al.
Publicado: (2019)

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose
por: Wong, Ka Kit, et al.
Publicado: (2018)

DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uacmrdsiktv9p0gd7bouveme37